These results indicate that ARID1A, as the subunit with the highest mutation rate in the SWI/SNF chromatin remodeling complex family, plays a role in tumor through the regulation of the above biological processes, and has broad application prospects in tumor development and targeted therapy. Here, SMARCA1 is linked to neoplasm.